Lynestrenol
CAS No. 52-76-6
Lynestrenol( —— )
Catalog No. M21287 CAS No. 52-76-6
Lynestrenol is a synthetic progestational hormone is the progesterone receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 67 | Get Quote |
|
| 50MG | 100 | Get Quote |
|
| 100MG | 149 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLynestrenol
-
NoteResearch use only, not for human use.
-
Brief DescriptionLynestrenol is a synthetic progestational hormone is the progesterone receptor agonist.
-
DescriptionLynestrenol is a synthetic progestational hormone is the progesterone receptor agonist.(In Vitro):Lynestrenol markedly enhances the lymphocyte response to phytohemagglutinin, the mixed lymphocyte culture, the active T-rosette test, the autologous red cell rosettes, and the number of nonadherent cells in the leukocyte adherence inhibition test. Lynestrenol also increases monocyte phagocytosis. Lynestrenol delays the appearance of malignant tumors in hamsters.(In Vivo):Lynestrenol has both a genotoxic and cytotoxic effects in mouse bone marrow cells. Lynestrenol is studied at three different doses (6.87, 13.75 and 27.50 mg/kg). Sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) increase significantly as compared to normal control when treated with Lynestrenol at 13.75 and 27.50 mg/kg.
-
In VitroLynestrenol markedly enhances the lymphocyte response to phytohemagglutinin, the mixed lymphocyte culture, the active T-rosette test, the autologous red cell rosettes, and the number of nonadherent cells in the leukocyte adherence inhibition test. Lynestrenol also increases monocyte phagocytosis. Lynestrenol delays the appearance of malignant tumors in hamsters.
-
In VivoLynestrenol has both a genotoxic and cytotoxic effects in mouse bone marrow cells. Lynestrenol is studied at three different doses (6.87, 13.75 and 27.50 mg/kg). Sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) increase significantly as compared to normal control when treated with Lynestrenol at 13.75 and 27.50 mg/kg.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
Recptorprogesterone receptor
-
Research AreaNeurological Disease
-
IndicationTranssexualism and Gender Dysphoria.
Chemical Information
-
CAS Number52-76-6
-
Formula Weight284.4
-
Molecular FormulaC20H28O
-
Purity>98% (HPLC)
-
SolubilityDMSO:56 mg/mL (196.87 mM)
-
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
-
Chemical Name19 Norpregn-4-en-20-yn-17-ol (17alpha)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Uzan S Denis C Pomi V et al. Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology 1992 43(3):219-227.
molnova catalog
related products
-
LSZ102
LSZ102 is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) with ERα transcription IC50 of 6 nM and ERα degradation IC50 of 0.2 nM.
-
Piceatannol 3'-O-glu...
Piceatannol 3'-O-glucoside increases pulmonary blood oxygen tension and decreases pulmonary interstitial edema, so it can protect lung injury.
-
Astragaloside IV
Astragaloside IV is generally considered to be the primary active ingredient in Astragalus extract,an herbal extract which has been famous for literally thousands of years for its anti-aging properties.
Cart
sales@molnova.com